SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/336D0E1C04CA3634ACD25AF7312176754837E81A9735EA033CC353B5B02348519DEB6BC39B57981F5A78A24DCD691E6E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/336D0E1C04CA3634ACD25AF7312176754837E81A9735EA033CC353B5B02348519DEB6BC39B57981F5A78A24DCD691E6E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/336D0E1C04CA3634ACD25AF7312176754837E81A9735EA033CC353B5B02348519DEB6BC39B57981F5A78A24DCD691E6E
http://www.w3.org/2000/01/rdf-schema#comment
"By improving hyperglycemia and promoting weight reduction SGLT2 inhibitor ipragliflozin may prove useful in treating type 2 diabetes in obese individuals."
xsd:string
http://purl.uniprot.org/uniprot/#_6745BD9B989CB78995420EBBDE0A6AF1BE22F9A1C8B497134D34EDA4BB3962D71881695BECB073AD8E4B5C5A3A8C6D81
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/336D0E1C04CA3634ACD25AF7312176754837E81A9735EA033CC353B5B02348519DEB6BC39B57981F5A78A24DCD691E6E
http://purl.uniprot.org/uniprot/Q8R520
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/336D0E1C04CA3634ACD25AF7312176754837E81A9735EA033CC353B5B02348519DEB6BC39B57981F5A78A24DCD691E6E
http://purl.uniprot.org/uniprot/#_Q8R520-mappedCitation-24486393
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/336D0E1C04CA3634ACD25AF7312176754837E81A9735EA033CC353B5B02348519DEB6BC39B57981F5A78A24DCD691E6E